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RNA loops that adopt a characteristic GNRA ‘‘tetraloop’’ fold are
common in natural RNAs. Here, we have used in vitro selection by
means of mRNA-peptide fusions to select peptides that bind an
example of this RNA loop motif. Starting with the RNA recognition
domain from the l N protein, we have constructed libraries
containing 150, 1,600, and 9 trillion different peptide sequences as
mRNA-peptide fusions and isolated those capable of high-affinity
RNA binding. These selections have resulted in more than 80
different peptides that bind the same RNA loop. The highest
affinity peptides exhibit low nanomolar dissociation constants as
well as the ability to discriminate RNA hairpins differing by a single
loop nucleotide. Thus, our work demonstrates that numerous,
chemically distinct solutions exist for a particular RNA recognition
problem.
The ability to construct high-affinity, high-specificity peptideligands provides a means to target RNA molecules of
interest. Genetic approaches have been developed to isolate
novel arginine-rich RNA-binding peptides in vivo (1–3). These
systems allow selection in the context of living systems, but limit
library sizes to a maximum of ;105 to 106 sequences, allowing
only four residues to be searched exhaustively (204 5 1.6 3 105).
In vitro selection experiments to isolate RNA-binding peptides
have not been demonstrated. An in vitro approach affords both
precise control of the selection environment and the ability to
explore much larger libraries.
We were interested in using in vitro selection to isolate
peptides that bind RNA tetraloops. The tetraloop fold is a
common element in many functional RNAs, enhancing duplex
stability and participating in tertiary folding interactions (4–6).
We had previously developed the mRNA-peptide fusion system
to perform in vitro selection on peptides and proteins (7). In the
fusion system, cycles are carried out entirely in vitro and libraries
of 1013 independent sequences can be constructed (Fig. 1A; refs.
7–10).
The arginine-rich peptide corresponding to the RNA-binding
domain of the l N protein served as a starting point for our
experiments and libraries. This short peptide (22 residues)
recognizes the boxBR RNA hairpin with high affinity and
specificity as a bent a-helix (11–14). The hairpin contains a
five-base RNA loop that adopts a tetraloop fold with one base
extruded (15, 16). Here, we have used in vitro selection exper-
iments to isolate peptides that bind the boxBR RNA motif.
Materials and Methods
Construction of Fusion Template. Templates and constructs used to
assay fusion binding (Fig. 2) correspond to the N-myc construct
described previously (17).
Binding Analysis. Chemically synthesized 39 biotinylated RNA
oligonucleotides of the l boxBR hairpin (Fig. 1B), HIV Rev
RRE binding site (59-GGUCUGGGCGCAGCGCAAGCU-
GACGGUACAGGCCAAA-39), and U1 stem-loop (59-
AAUCCAUUGCACUCCGGAUUAAA-39) were immobilized
on streptavidin agarose beads. Samples were added to 400 ml of
N binding buffer (10 mM Hepes pH 7.5y0.5 mM EDTAy100 mM
KCly1 mM MgCl2y1 mM DTTy0.01% Nonidet P-40y10% glyc-
erol) containing 50 mg/ml yeast tRNA and 200 pmol of immo-
bilized RNA. This mixture was incubated at 4°C for 1 h and then
washed in a filter centrifuge tube with binding buffer without
tRNA. Sample was eluted with either 23 tricine sample buffer
(0.1 M TriszCl pH 6.8y24% glyceroly8% SDSy0.2 M DTTy
0.02% Coomassie blue G-250) or 100 mM MgCl2.
Library Construction. Library 1 was constructed beginning with the
N-FLAG-myc synthetic single-stranded DNA (17) containing
the sequence 59-NNCBNG-39 (n 5 A,T, G, or C; B 5 C,G, or
T) at codons 6 and 7. This pool encodes the peptide MDAQT X6
X7RERRAEKQAQWKAANDYKDDDDKNSCA. The two
random positions, X6 and X7 encode the amino acids
FLIVSPTAYHNDCRG at position 6 and LVSPAQEWRG at
position 7, respectively. The single sequence that encodes R6R7
encodes an overlapping NgoM IV restriction site. Library 2 was
constructed as library 1 and by using a template containing
59-CNG-39 at codon 7 and the sequence NNS (S 5 G, C) at
codons 14 and 15. This combination encoded L, P, Q, or R at
position 7 and all 20 aa at positions 14 and 15. Library 3 was
constructed by inserting NNS codons at residues 13–22 in the
N-myc template (17). PCR library construction began with 150
pmols of synthetic DNA which extended 76% yielding a library
containing ;6.9 3 1013 sequences. In round 1, 200 pmols of
RNA-puromycin conjugate was translated and ’15 pmols of
fusion were purified and subjected to the selective step resulting
in an initial library complexity of ;9 3 1012 sequences.
Selection Experiments. The library 1 and library 2 selection rounds
were carried out essentially as described (17). In the library 3
selection, selection rounds omitted thiopropyl Sepharose chro-
matography and preclear. Sequencing of round 11 clones indi-
cated that a number corresponded to the wild-type (wt) l N
control construct of our original experiments, resulting from
microscopic contamination of the round 0 pool. This sequence
is unlikely to have influenced the pool composition or the
selection because of the excess of target RNA in the selective
step. The wt sequence was removed during round 12 by sub-
tractive hybridization. A total of 2,000 pmol of round 11 fusion
template was incubated in 1 ml of subtractive hybridization
buffer (1 M NaCl; 100 mM TriszCl, pH 8.0y10 mM EDTA) for
1 h at 4°C with 5 mM biotinylated anti-wt oligo (59-
GTTGGCGGCCTTCCACTGGGCCTGCTTCTCAAA-Bi-
otin) immobilized on streptavidin agarose. The eluent was saved
and subjected to the procedure two additional times. This
process was efficient as none of the round 12 clones contained
the wt sequence.
Quantitation by Affinity Precipitation. Peptides for each clone were
produced by 35S-Met-labeled in vitro translation of the mRNA
alone under conditions identical to fusion synthesis (17). For
Abbreviation: wt, wild type.
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library 2 peptides (Fig. 3), 10 ml of crude lysate was mixed with
1 ml 200 nM immobilized boxBR in N binding buffer, washed five
times with N-binding buffer and eluted with RNase A (Roche
Molecular Biochemicals). For library 3 peptides (Fig. 4), 6–7.5
ml of crude translation reaction was mixed with 160 nM of all
three immobilized hairpins in 500 ml of N binding buffer and 50
mg/ml yeast tRNA for 1 h at 4°C and was eluted in tricine loading
buffer. In both cases, the eluted peptides were run adjacent to
a sample of the translation reaction on a tricine–SDS polyacryl-
amide gel (21), and the percentage of peptide bound was
determined by PhosphorImager counting (Molecular Dynamics)
of the respective gel bands.
Fluorescence-Binding Measurements. Peptides were constructed by
means of automated synthesis and fluorenylmethloxycarbonyl or
t-butyloxycarbonyl monomers. Crude peptides were purified as
single peaks by means of reversed-phase HPLC and the identity
was confirmed by mass spectrometry. RNA hairpins containing
2-amino purine at the second loop position (denoted 2AP-2,
Table 1; substitution for A8) were constructed by automated
RNA synthesis by using 29-O-methyl 2-aminopurine phosphor-
amidite (Glen Research, Sterling, VA).
Fluorescence measurements were made essentially as in La-
courciere et al. (22), with excitation and emission wavelengths of
310 and 370 nm, respectively. Concentrated peptide was added
stepwise to a stirred solution of 20 nM to 800 nM 2AP-2 RNA
hairpin and the temperature was maintained at 20°C.
CD Spectroscopy. Spectra were taken on an Aviv 62 DS CD
spectrometer at 25°C. The samples contained 5 mM RNA and 6
mM peptide in 10 mM potassium phosphate buffer (pH 7.9). The
spectra of the bound peptides were determined by subtracting
the free RNA and excess free peptide spectra from the spectra
of the complex.
NMR Sample Preparation. BoxBR RNA 59-GCCCUGAAAA-
AGGGC-39 (15-mer) was synthesized by in vitro transcription by
using T7 RNA polymerase. The RNA was purified by 20%
urea-PAGE, desalted on a NAP column (Amersham Pharma-
cia), freeze-dried, and resuspended in NMR buffer (50 mM
NaCly10 mM phosphate, pH 6) in H2OyD2O (90:10, vol/vol).
Complexes between the wt l N (1–22) or 11–36 (1–22) and
boxBR RNA were generated by addition of concentrated (’10
mM) peptide to boxBR RNA (280 mM) with the stoichiometry
monitored by inspecting the imino–proton spectra. The final
sample concentrations were ’250 mm for the free RNA and 280
mM for both RNA and peptide in the complexes.
NMR Spectroscopy. NMR spectra were collected at 25°C on a
Varian INOVA 600-MHz spectrometer. A modified double
gradient echo Watergate solvent-suppression pulse sequence
was used to suppress the solvent peak (23). Assignments were
based on reported work (13, 15, 16).
Results and Discussion
It was unclear a priori whether an RNA-binding peptide would
be functional as either a mRNA-peptide or cDNAymRNA-
peptide fusion. We synthesized mRNA-peptide fusions contain-
ing the l-N RNA binding domain (17) (Fig. 1B) and tested the
ability of these molecules to bind an immobilized target. Fig. 2
shows that both the mRNA-peptide fusion and the cDNAy
mRNA-peptide fusion specifically bind the boxBR RNA target.
These assays demonstrate that a significant fraction of the
desired complex can be isolated (30–60%) whereas little (1–5%)
is retained if noncognate biotinylated RNA targets (Rev Re-
sponse Element, RRE; U1 RNA hairpin loop II, U1) are used
instead of the boxBR RNA.
We designed three selections to test our ability to isolate novel
tetraloop-binding peptides. In selection 1, we randomized posi-
tions 6 and 7 of the wt construct. At these positions, previous
mutagenesis and structural work indicated a single sequence,
R6R7, should be optimal for binding. The cassette contained 150
different amino acid combinations, only one of which was R6R7.
We performed selection 1 (one round), three times in parallel,
Fig. 1. (A) Selection cycle. (B) Constructs used. In the selection cycle, a
double-stranded DNA library containing randomized codons is transcribed,
generating a pool of mRNA templates. These templates are then ligated to a
flexible DNA oligonucleotide containing puromycin at its 39 end. Translation
of these ligated templates in vitro produces peptides covalently attached by
means of their C terminus to the 39 end of their own message by way of a stable
amide linkage—a mRNA–peptide fusion. These fusions are then converted
into cDNAymRNA hybrid fusions by using reverse transcriptase and subjected
to selection on an affinity matrix.
Fig. 2. Binding and specificity of l N peptide l N mRNA-peptide fusion, and
l N cDNAymRNA-peptide fusion constructs. (A) Gel analysis of binding. Bind-
ing of 35S-Met-labeled l N mRNA-peptide fusions and cDNAymRNA-peptide
fusions to immobilized (i) l boxBR (lanes 2 and 6), (ii) HIV-RRE (lanes 3 and 7)
and (iii) U1 hairpin (lanes 4 and 8). Lanes 1 and 5 show the total amount of
fusion before binding. Complexes were eluted and resolved on SDS tricine
PAGE (21). (B) Scintillation analysis of binding and specificity. 35S-Met-labeled
peptide, mRNA, and mRNAycDNA fusions bound to immobilized boxBR,
HIV-RRE, and U1 hairpins. The cDNAymRNA and mRNA fusions bind the
cognate boxBR RNA efficiently, whereas only 1–5% bind the RRE and U1
targets.
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by using increasing concentrations of competitor tRNA to
provide high stringency selection. A majority (85%) of the
selected clones contained R6R7 when 5 mg/ml tRNA competitor
was used. Thus, increased competitor allowed good enrichment
(50- to 150-fold per round) without forcing us to make the target
the limiting reagent (18).
In selection 2 (Fig. 3A, library 2) we randomized positions 7,
14, and 15, which total 1,600 possible combinations. In the wt l
NyboxB complexes, residues 14 and 15 lie at the RNA-peptide
interface (15, 16) and are important for binding (1, 14). After
four rounds of selection, the pool binding was similar to the wt
sequence (Fig. 3B). Analysis of 39 round-4 clones yielded 19
different sequences (Fig. 3C). Each peptide was constructed by
means of in vitro translation, and the binding was assayed to
immobilized boxBR RNA (Fig. 3C). All of the corresponding
peptides bind the boxBR RNA and contain arginine at position
7. Aside from the wt (K14Q15), only three of the highest-affinity
clones show identity with the original two residues. Indeed, a
different sequence containing R15 emerges as a dominant motif,
including E14R15, replacing lysine-14 with glutamic acid.
Peptides corresponding to wt l N (1–22) and l N (1–22;
E14R15) were constructed synthetically, and the binding to the
boxBR RNA was measured (Table 1). Both peptides bind with
high affinity to the target site (1.9 nM vs. 8.5 nM). The difference
is small considering that a single change of K14 to A14 results in
loss of more than 2 kcal/mol (13). The high specificity of l N
(1–22; E14R15) may also have played an important role in its
selection. The appearance of glutamic acid, though puzzling
because of its negative charge, may result from favorable inter-
action with the helix dipole of residues 12–22 (19, 20).
Selection 3 was designed by randomizing positions 13–22 in the
wt l N peptide, creating a library near the complexity limit of the
Fig. 3. Selection of l boxBR binding peptides from library 2. (A) Sequence of
library 2. The target is the boxBR RNA (Fig. 1B). Peptide position 7 contains a
cassette encoding 4 amino acids, whereas positions 14 and 15 encode all 20
possible amino acids and one stop codon (NNGyC codons). (B) Binding to
immobilized boxBR RNA for rounds 0–4 measured by using 35S-Met-labeled
fusions. Controls using the wt complex (WT) and agarose with no immobilized
RNA (no boxBR) are shown. Material from the fourth round (colored bar) was
cloned and sequenced. (C) Peptide sequences and peptide-binding affinities
of selected clones. Binding affinities are given relative to the wt sequence in
the same construct.
Fig. 4. Selection of RNA-binding peptides from library 3. (A) Sequence of
library 3 and the three RNA targets used (l-boxBR, GNRA tetraloop, and P22
boxBL). Positions of identity are shown as circles. All three stems are identical.
The resulting P22 stem differs from the wt sequence by 1 bp. (B) Binding of the
rounds 0–11 mRNA-peptide pools (35S-Met-labeled) to beads containing all
three immobilized hairpins. (C) Peptide sequences and binding affinities from
rounds 11 and 12. The relative binding affinity as compared with the wt
boxBRyl N interaction is given. (D) Consensus sequence of selected clones. The
residues are color-coded by amino acid type (green, hydrophobic; red, posi-
tively charged; blue, negatively charged; and yellow, polar) and the height
indicates the occurrence frequency of each residue.
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mRNA-peptide fusion method. The selection was conducted
versus three different RNA targets differing only in their loop
structures: (i) the boxBR, (ii) a GNRA tetraloop, and (iii) the
P22 loop (Fig. 4A). Previous structural work indicated that the
C-terminal helix might discriminate between different loops
because it contacts the loop in the l NyboxB structure (15, 16).
Additionally, the N-terminal arginine-rich region shows conser-
vation in N proteins from Escherichia coli phages l and f21, and
Samonella phage p22, despite differences in the RNA tar-
gets (11).
Library 3 (Fig. 4A) began with ;9 trillion individual se-
quences, capturing the majority of the 10 trillion possible 10-aa
cassettes that could exist in the library. We performed 12 rounds
of selection against an equimolar mixture of three hairpins (Fig.
4 A and B; rounds 1–11). Binding to any one of the three hairpins
was sufficient to allow a peptide to be selected, because each
target exceeded the total number of moles of fusion peptide in
the selective step. Binding stringency was controlled by addition
of yeast tRNA (5 mg/ml) as a nonspecific competitor, rather than
limiting target.
The sequences isolated from rounds 11 and 12 are shown in
Fig. 4C. We generated 35S-Met-labeled peptides for 23 individual
clones by means of in vitro translation, and we measured the
fraction of each peptide that bound a mixture of the three
hairpins (Fig. 4C). These experiments indicated that each pep-
tide tested could bind at least one of the hairpins in the mixture.
The specificity of seven individual clones, the round 11 and
round 12 pools were then tested by using each individual hairpin.
All showed a marked preference for the boxBR RNA as
compared with the GNRA or P22 targets (data not shown).
Peptides corresponding to five of the selected sequences were
constructed synthetically, and the binding constants to all three
hairpins were measured by fluorescence titration (Table 1,
selection 3; Fig. 5A). All show high affinity (Kd # 3.5 nM) for the
boxBR target, with two showing equal or better affinity than the
wt l N (1–22) peptide itself. The specificity of the sequences is
also quite high, with both 11–36 and 11–10 showing better
specificity than wt l N, particularly against the GNRA hairpin.
Given the similar specificity of the peptides, it is surprising
how dissimilar the sequences are when compared with wt l N.
On average, there is less than one match per insert. Further,
positions known to be important in the binding of l N (W18, K14,
and Q15) show little conservation. There is no similarity with N
sequences derived from phages P22 or f21 (11). Only one
Table 1. Binding constants and specificity of selected and
control peptides
Name
BoxBR
(2AP-2),
nM
GNRA
(2AP-2),
nM
P22
(2AP-2),
nM
l N (1-22) 1.0 6 0.2 9.0 6 0.7 41 6 3
Selection 2
l N (1-22; E14R15) 8.5 6 2 800 6 150* 580 6 20
Selection 3
12-50 (1-22) 0.4 6 0.1† 9 6 2 14 6 1
12-39 (1-22) 0.5 6 0.1† 6.5 6 0.7 8.4 6 0.8
11-10 (1-22) 1.9 6 0.5† 93 6 9 140 6 10
11-36 (1-22) 3.0 6 0.2† 288 6 7 246 6 7
12-47 (1-22) 3.4 6 0.1 81 6 2 60 6 3
Controls
l N (1-11) 1,290 6 20 19,000 6 800 63,000 6 7,200
l N (1-15; E14R15) 303 6 8 7,500 6 300 12,300 6 200
11-36 (1-22) scrambled 210 6 25 3,400 6 200 10,700 6 200
12-47 (1-22) scrambled 140 6 12 2,000 6 80 5,200 6 100
Binding constants were determined by fluorescence titration at 20°C, 50
mM KOAcy20 mM TriszOac, pH 7.5. All peptides contain a free amino and
carboxyl terminus. l N (1-11), l N (1-15, E14R15), 11-36 (1-22) scrambled, and
12-47 (1-22) scrambled contain a C-terminal GY sequence to facilitate quan-
titation. 2AP-2 denotes a 29-methoxy 2-aminopurine residue inserted at the
second loop position. Error estimates indicate the precision of individual fits.
Data for ERV from selection 2 indicates the binding is similar to l N (1-22,
E14R15; unpublished observation).
*Contains high uncertainty due to a small fluorescence change upon peptide
addition.
†Indicates values determined by extrapolation from higher salt.
Fig. 5. Properties of 11–36 (1–22) vs. wt l N (1–22). (A) Binding isotherm for
11–36 (1–22) and wt l N (1–22) detected by fluorescence of 2AP-2-labeled
boxBR in 100 mM KOAcy20 mM TriszOAc. The fluorescence of the RNA is
quenched by wt l N (1–22) and enhanced by 11–36 (1–22). (B) CD spectra of
11–36 (1–22) and wt l N (1–22). (C) NMR spectra of the BoxBR RNA alone and
complex with the wt l N (1–22) or 11–36 (1–22) peptides. Both peptides protect
the G loop nucletide from exchange (10.7 ppm) and give rise to similar amino
spectra in the RNA stem.
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sequence, 12–46, contains W18, a residue that cannot be changed
in wt l N without impairing binding (13). Sequence 12–46 is also
the only clone that contains K14, revealing that these two
positions may be energetically coupled. NMR and fluorescence
analysis of a series of mutants at positions 14, 15, and 18 supports
this notion (J.R., T.X, T.T.T., and R.W.R. unpublished data).
The selected peptides are somewhat similar to each other,
showing an average identity of ;2.5 residues per cassette when
individual clones are compared. The identity results largely from
strong conservation of R15 and partial conservation of E14 and
L22 (Fig. 4D). Modeling R15 into the l N structure reveals a
possible basis for this conservation—a side chain to main-chain
H bond can be formed for both Q15 (wt) and R15. In the R15
model, this H bond would orient the positively charged guani-
dinium side chain directly toward the A8 and A9 phosphates.
l N (1–11) and l N (1–15; E14R15) peptides were synthesized
to address the specificity of selected clones and the conserved
arginine (Table 1, controls). Surprisingly, l N (1–11) shows the
same selectivity with the full-length recognition domain, l N
(1–22). Binding to the GNRA and P22 hairpins shows a DDG°
of 1.3 and 2.2 kcal/mol for l N (1–22), whereas the binding of l
N (1–11) shows DDG° values of 11.6 and 12.3 kcal/mol. Thus the
origin of specificity for the peptide appears to be conferred by
the N-terminal 11 residues.
This bias provides an explanation as to why isolation of GNRA
and P22 binders proved so challenging—P22- or GNRA-specific
clones would require the random region to provide an extra 1.3–2.3
kcal/mol in binding free energy as compared with the boxBR
hairpin. In principle, it should be possible to find peptides in the
library with specificity for P22 or the GNRA loop. However, further
selection for peptides specific to these two hairpins has not resulted
in sequences with swapped specificity (J.E.B. and R.W.R., unpub-
lished observations). Unresolved is how the l N (1–11) peptide
discriminates between three hairpins that differ by a single loop
nucleotide. The specificity of l N (1–11) reveals that despite the
sequence identity, these three hairpins may have different global
structures before peptide binding.
We synthesized a number of peptides to address the role of the
residues between positions 13 and 22. The l N (1–15; E14R15)
peptide reveals that addition of R15 cannot be the sole feature
that confers low nanomolar binding to the selected peptides.
Adding the sequence containing E14R15 to the l N (1–11)
peptide confers only a 3- to 5-fold enhancement in Kd, a DDG°
of 20.7 to 21.0 kcal/mol (Table 1, l N 1–15; E14R15). This result
indicates that sequences between positions 16 and 22 contribute
;3 kcal/mol of binding free energy to the interaction.
We then constructed versions of peptides 12–47 and 11–36 in
which the selected insert was scrambled [12–47 (scrambled) 5
MDAQTRRRERRAELELLTRKKA-GY; 11–36 (scram-
bled) 5 MDAQTRRRERRATAPEQVMLR-GY] (Table 1,
Controls). If net positive charge and a propensity to form
a-helices were sufficient in the random region, then the exact
order of the residues should not impair binding. Comparison of
the round 11 and round 12 clones with the starting library reveals
a net positive charge in the insert and overrepresentation of
amino acids that are good helix formers. However, the scrambled
sequences show a loss of ;100-fold in Kd relative to the
unscrambled peptides (130 6 12 nM and 220 nM 6 25, Table 1).
Thus, the precise order of residues is necessary to obtain
maximal affinity.
Finally, we examined the structure and properties of the 11–36
(1–22) complex as compared with l N (1–22). The fluorescence
titration provides a clear demonstration that the detailed inter-
actions are different in the two complexes (Fig. 5A). Addition of
l N (1–22) produces strong quenching with the 2AP-2 probe,
whereas 11–36 enhances the fluorescence at that position.
Quenching in the l N (1–22)yboxBR complex is expected, as W18
is quenched in the complex (13) and should stack directly on top
of 2AP-2 (15, 16). In contrast, 11–36 contains no aromatic amino
acids. In previous work, 2AP quenching or enhancement has
been interpreted as the result of increased or decreased stacking
(22). This finding implies that the adenine at loop position 2 is
likely less stacked in the 11–36 complex than it is in the free
RNA. Profound distortion of the loop is unlikely, though, as both
peptides support folding of the tetraloop motif as judged by
appearance of the G loop imino at ;10.8 ppm (Fig. 5C).
In the CD spectra, neither peptide shows any appreciable
structure in the absence of RNA (Fig. 5B). The difference
spectra of the complex indicates that both peptides fold into
a-helices when bound to the RNA (Fig. 5B). Although globally
similar, the two complexes display differences in regions indic-
ative of peptide folding (200–225 nm) and RNA folding (260–
300 nm). The detailed structure is thus somewhat mercurial and
depends on which peptide is bound.
Our results demonstrate that high-affinity RNA ligands may
be isolated by using in vitro selection. The large starting library
resulted in a great diversity of solutions to this bindingy
recognition problem. Although general features such as helix
propensity and charge may assist recognition, no code for
recognition is discernable. Rather, our results are more consis-
tent with a model where RNA-peptide interactions are highly
context dependent. In that vein, the combinatorial approach we
have used provides a powerful design strategy for interactions
where rules may be idiosyncratic at best.
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